These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 22341342)
1. Phenacetin O-deethylation is a useful tool for evaluation of hepatic functional reserve in rats with CCl(4)-induced chronic liver injury. Liu Z; Qu Z; Li X; Cai M; He P; Zhou M; Xiao J; Wang X J Surg Res; 2012 Jun; 175(2):e61-6. PubMed ID: 22341342 [TBL] [Abstract][Full Text] [Related]
2. Effect of dimethyl sulfoxide on in vitro cytochrome P4501A2 mediated phenacetin O-deethylation in human liver microsomes. Nirogi R; Kandikere V; Bhyrapuneni G; Ponnamaneni RK; Palacharla Rc; Manoharan A Drug Metab Dispos; 2011 Nov; 39(11):2162-4. PubMed ID: 21825116 [TBL] [Abstract][Full Text] [Related]
3. The impaired disposition of probe drugs is due to both liver and kidney dysfunctions in CCl(4)-model rats. Zhang Y; Jia Y; Yang M; Yang P; Tian Y; Xiao A; Wen A Environ Toxicol Pharmacol; 2012 May; 33(3):453-8. PubMed ID: 22407168 [TBL] [Abstract][Full Text] [Related]
4. The 3-methylcholanthrene-mimetic effect of 4,4'-dichlorobiphenyl-treatment on phenacetin-induced hepatic glutathione depletion and liver microsomal phenacetin O-deethylation in rats. van Bree L; Redegeld FA; de Vries J Toxicology; 1986 Dec; 42(2-3):259-74. PubMed ID: 3099430 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of antiarrhythmic drugs on phenacetin O-deethylation catalysed by human CYP1A2. Kobayashi K; Nakajima M; Chiba K; Yamamoto T; Tani M; Ishizaki T; Kuroiwa Y Br J Clin Pharmacol; 1998 Apr; 45(4):361-8. PubMed ID: 9578183 [TBL] [Abstract][Full Text] [Related]
6. Effect of albumin on human liver microsomal and recombinant CYP1A2 activities: impact on in vitro-in vivo extrapolation of drug clearance. Wattanachai N; Tassaneeyakul W; Rowland A; Elliot DJ; Bowalgaha K; Knights KM; Miners JO Drug Metab Dispos; 2012 May; 40(5):982-9. PubMed ID: 22331994 [TBL] [Abstract][Full Text] [Related]
7. Effect of malaria infection and endotoxin-induced fever on phenacetin O-deethylation by rat liver microsomes. Kokwaro GO; Glazier AP; Ward SA; Breckenridge AM; Edwards G Biochem Pharmacol; 1993 Mar; 45(6):1235-41. PubMed ID: 8466544 [TBL] [Abstract][Full Text] [Related]
8. Mechanism-based inhibition of CYP1A2 by antofloxacin, an 8-NH2 derivative of levofloxacin in rats. Zhu Q; Liao J; Xie L; Wang GJ; Liu XD Xenobiotica; 2009 Apr; 39(4):293-301. PubMed ID: 19350452 [TBL] [Abstract][Full Text] [Related]
9. Kinetics and inhibition by fluvoxamine of phenacetin O-deethylation in V79 cells expressing human CYP1A2. Jensen KG; Poulsen HE; Doehmer J; Loft S Pharmacol Toxicol; 1995 Apr; 76(4):286-8. PubMed ID: 7617560 [TBL] [Abstract][Full Text] [Related]
10. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. Tassaneeyakul W; Birkett DJ; Veronese ME; McManus ME; Tukey RH; Quattrochi LC; Gelboin HV; Miners JO J Pharmacol Exp Ther; 1993 Apr; 265(1):401-7. PubMed ID: 8474022 [TBL] [Abstract][Full Text] [Related]
11. Phenacetin O-deethylation in extrahepatic tissues of rats. Cui ZF; He P; Luo M; Xia SQ; Wu MC Eur J Drug Metab Pharmacokinet; 2002; 27(2):107-11. PubMed ID: 12064368 [TBL] [Abstract][Full Text] [Related]
12. [O-ethyl 14C]phenacetin O-deethylase activity in human liver microsomes. Rodrigues AD; Surber BW; Yao Y; Wong SL; Roberts EM Drug Metab Dispos; 1997 Sep; 25(9):1097-100. PubMed ID: 9311627 [TBL] [Abstract][Full Text] [Related]
13. A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking. Sesardic D; Boobis AR; Edwards RJ; Davies DS Br J Clin Pharmacol; 1988 Oct; 26(4):363-72. PubMed ID: 3190986 [TBL] [Abstract][Full Text] [Related]
14. Intermolecular interactions of antimicrobial fluoroquinolones with purified rat liver CYP1A2 studied by proton nuclear magnetic resonance spectroscopy. Mizuki Y; Yamamoto K; Yamaguchi T; Fujii T; Miyazaki H; Ohmori H Xenobiotica; 1996 Oct; 26(10):1057-66. PubMed ID: 8905919 [TBL] [Abstract][Full Text] [Related]
15. CYP2A13 metabolizes the substrates of human CYP1A2, phenacetin, and theophylline. Fukami T; Nakajima M; Sakai H; Katoh M; Yokoi T Drug Metab Dispos; 2007 Mar; 35(3):335-9. PubMed ID: 17178771 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the assumptions of an ontogeny model of rat hepatic cytochrome P450 activity. Alcorn J; Elbarbry FA; Allouh MZ; McNamara PJ Drug Metab Dispos; 2007 Dec; 35(12):2225-31. PubMed ID: 17881659 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the activity of P450 enzymes in rats: use of the single marker or combined drug administration. Jurica J; Kyr M; McCaskey Hadasova E; Tomandl J Neuro Endocrinol Lett; 2009; 30 Suppl 1():92-5. PubMed ID: 20027151 [TBL] [Abstract][Full Text] [Related]
18. Effects of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on rat CYP1A2 expression and metabolism of model CYP1A2 probe substrates. Wang X; Lee WY; Or PM; Yeung JH Phytomedicine; 2009 Aug; 16(8):712-25. PubMed ID: 19403289 [TBL] [Abstract][Full Text] [Related]
19. Effects of Ziziphus jujuba fruit extracts on cytochrome P450 (CYP1A2) activity in rats. Jing XY; Peng YR; Wang XM; Duan JA Chin J Nat Med; 2015 Aug; 13(8):588-94. PubMed ID: 26253491 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of baicalin on metabolism of phenacetin, a probe of CYP1A2, in human liver microsomes and in rats. Gao N; Qi B; Liu FJ; Fang Y; Zhou J; Jia LJ; Qiao HL PLoS One; 2014; 9(2):e89752. PubMed ID: 24587011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]